Tenon Medical Inc. (TNON)
NASDAQ: TNON
· Real-Time Price · USD
0.88
-0.00 (-0.01%)
At close: Jun 16, 2025, 3:59 PM
0.88
-0.20%
After-hours: Jun 16, 2025, 05:55 PM EDT
-0.01% (1D)
Bid | 0.88 |
Market Cap | 6.7M |
Revenue (ttm) | 3.28M |
Net Income (ttm) | -13.71M |
EPS (ttm) | -2.25 |
PE Ratio (ttm) | -0.39 |
Forward PE | -0.99 |
Analyst | Buy |
Ask | 0.9 |
Volume | 150,418 |
Avg. Volume (20D) | 6,367,760 |
Open | 0.87 |
Previous Close | 0.88 |
Day's Range | 0.86 - 0.90 |
52-Week Range | 0.85 - 15.79 |
Beta | 1.23 |
About TNON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TNON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TNON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-35.47%
Tenon Medical shares are trading lower after the c...
Unlock content with
Pro Subscription
2 months ago
+283.4%
Tenon Medical shares are trading higher on possible continued strength after the company announced yesterday that it has received FDA 510(k) clearance for its Catamaran St Joint Fusion System.

1 month ago · accessnewswire.com
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial ResultsLOS GATOS, CA / ACCESS Newswire / April 29, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...

2 months ago · accessnewswire.com
Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results~ Full Year 2024 Revenue of $3.3 Million, a 12% Increase Compared to Prior Year ~ ~ Interim Analysis from MAINSAIL Study Reinforces Safety Profile, Effectiveness and Confirmation of Fusion ~ ~ Catamar...